Deva Pharma SRL
The score of Deva Pharma shows with a free account.
See the score- Summary? / 5
- Solvency
- Liquidity
- Interest coverage
- Profitability
- Leverage
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +38 % Total assets +5 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deva Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 93,689 € | ||||
| Equity | 673,541 € | ||||
| Cash | 118,740 € | ||||
| EBITDA | 141,862 € | ||||
| Total assets | €1.02m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jun 2026
- Year ended 31 Dec 2024filed on 01 Jul 2025
- Year ended 31 Dec 2023filed on 02 Jul 2024
- Year ended 31 Dec 2022filed on 03 Jul 2023
- Year ended 31 Dec 2021filed on 11 Jul 2022
Deva Pharma's financial analysis
- Solvency65.7%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Deva Pharma
Deva Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0847.315.091
- VAT number
- BE0847315091
- Peppol
- Registered · 0208:0847315091 · as of 17 Oct 2026
- Legal form
- SRL
- Incorporated
- 03 Jul 2012
- Registered office
- 8710 Wielsbeke
- Latest accounts
- 2025 · filed on 29 Jun 2026
- Activity
- Activities of holding companies (NACE 64210)
Deva Pharma (SRL) has been based in Wielsbeke since 2012, active in: activities of holding companies. For 2025, it reports a net profit of 93,689 € and equity of 673,541 €; its revenue is not published. Its solvency stands at 65.7%, above the median of its sector (55.6%).
Companies similar to Deva Pharma
Companies in the same business, of comparable size and area, outside its group.
- Klaas Invest Activities of holding companies Ghent · balance sheet €1.02m
- Newport Invest Activities of holding companies Nieuwpoort · balance sheet €1.02m
- Liebert Group Activities of holding companies Sint-Genesius-Rode · balance sheet €1.03m
- Wiann Invest Activities of holding companies Herk-de-Stad · balance sheet €1.03m
- GCorp Activities of holding companies Neufchâteau · balance sheet €1.03m
- Collignon Management Activities of holding companies Érezée · balance sheet €1.03m
- Rostekop Activities of holding companies Ghent · balance sheet €1.03m
- Oculus Mr. Boo Activities of holding companies Antwerp · balance sheet €1.02m
Frequently asked questions about Deva Pharma
What is the revenue of Deva Pharma?
Deva Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Deva Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0847315091 for Deva Pharma, if the company is VAT-registered. Its company number (CBE) is 0847.315.091.
Where is the registered office of Deva Pharma?
According to the CBE register, the registered office of Deva Pharma is in 8710 Wielsbeke.
What is the equity of Deva Pharma?
At the close of the 2025 financial year, the equity of Deva Pharma amounts to 673,541 €, a solvency of 65.7% of total assets.
Who manages Deva Pharma?
The register lists 1 active mandates at Deva Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Deva Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →